Results 161 to 170 of about 527,356 (286)

Young-Onset Type 2 Diabetes and Its Association with Variant Angina in an Adolescent. [PDF]

Am J Case Rep
Liu Y, Zhang Y, Zhao W, Zhu G.
europepmc   +1 more source

Incidence and factors associated with mortality in 2,476 patients with variant angina in Korea. [PDF]

Sci Rep, 2017
Kim HL, Kim J, Kim HJ, Lim WH, Lee JY.
europepmc   +1 more source

Clinical characteristics and in‐hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open‐loop era: A UK‐wide MINAP registry analysis

Diabetic Medicine, EarlyView.
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Harshal Deshmukh, Moosa Shaikh, Emma G. Wilmot, Eric Kilpatrick, Sudipta Chattopadhyay, Thozhukat Sathyapalan, Joseph John   +6 more
wiley   +1 more source

ST Segment Elevation Myocardial Infarction as a Potentially Fatal Outcome of Variant Angina: A Case Report. [PDF]

Acta Cardiol Sin
Öztürk C, Özkan U, Çakır B, Ebik M, Yalta K.   +4 more
europepmc   +1 more source

Recurrent myocardial infarction secondary to Prinzmetal's variant angina. [PDF]

Singapore Med J, 2015
Murdoch D, Dhillon P, Niranjan S.
europepmc   +1 more source

Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest, Priyanka Majety, Stéphanie B. Mayer, Om P. Ganda   +3 more
wiley   +1 more source

A 52‐Week Efficacy and Safety Study of Teneligliptin, as an Add‐On to Empagliflozin and Metformin in Patients With Type 2 Diabetes Mellitus: A Randomised, Double‐Blind, Placebo‐Controlled Phase 3 Trial (TERA305 Study)

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the long‐term efficacy and safety of teneligliptin add‐on in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin. Materials and Methods In this randomised, double‐blind, phase 3 trial, 214 patients received teneligliptin 20 mg (n = 107) or placebo (n = 107) once daily for 24 ...
Jun Sung Moon, Kyung Ah Han, Dong‐Lim Kim, Sang Yong Kim, Soo‐Kyung Kim, Bon Jeong Ku, Woo Je Lee, Tae Keun Oh, Ji A Seo, Sang‐Ah Chang, Moon‐Kyu Lee, Kyu Jeung Ahn, Chul Sik Kim, Tae Nyun Kim, Bong‐Soo Cha   +14 more
wiley   +1 more source

Variant Angina

International Journal of Clinical & Medical Imaging, 2016
Kishore Kumar, Phyo Thet
openaire   +1 more source

Variant angina

The Journal of Thoracic and Cardiovascular Surgery, 1979
Richard C. Pasternak, Adolph M. Hutter, Roman W. DeSanctis, Marlene F. JaRo, Mortimer J. Buckley   +4 more
openaire   +1 more source

Cost‐Effectiveness of a Culturally Adapted Diabetes Self‐Management Education Program for Marshallese Adults With Type 2 Diabetes‐a State‐Transition Markov Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To assess the health and economic consequences of a culturally adapted family‐model diabetes self‐management education (adapted DSME) program for Marshallese adults with type 2 diabetes (T2D) compared with standard DSME and usual care. Methods A state‐transition Markov model was constructed to predict costs and quality‐adjusted life years (
Daniel Lamprecht‐Carson, Hongmei Wang, Su‐Hsin Chang, Pearl A. McElfish, Jennifer A. Andersen, Tzeyu L. Michaud   +5 more
wiley   +1 more source